SILVER SPRING, Maryland — Members of a U.S. advisory panel agreed with a Food and Drug Administration analysis that found antidepressant use raises the risk of suicidal thoughts and behavior in adults up to age 25, the panel’s chairman said on Wednesday.

The panel also agreed the risk starts to decline beyond age 30, said panel chairman Dr. Daniel Pine. The committee still was discussing if new warnings should be added to the medicines, which include Pfizer Inc.’s Zoloft and Eli Lilly and Co.’s Prozac.

Source: Reuters

No Responses to “Panel agrees on young adult antidepressant risk”


Leave a Reply